Tag - NMTC

Markets

AGP starts NeuroOne Medical at buy; PT $5.75

Alliance Global Partners launched coverage of NeuroOne Medical Technologies (NASDAQ:NMTC) with a “buy” rating and price target of $5.75. The stock closed at $2.09 on Dec. 2. NeuroOne’s flexible, thin-film...

December 3, 2021

Feature

NeuroOne developing electrode technology to treat neurological conditions

NeuroOne (OTCQB:NMTC) is developing high-definition, minimally invasive thin-film electrodes for the diagnosis and treatment of various neurological conditions, including epilepsy, Parkinson’s disease (PD) and chronic...

July 14, 2020

Executive Moves

NeuroOne appoints neural engineering expert, Camilo Andres Diaz-Botia, as director of electrode development

Camilo Andres Diaz-Botia NeuroOne Medical Technologies (OTCQB:NMTC) appointed neural engineer, Camilo Andres Diaz-Botia, as director of electrode development. Dr. Diaz-Botia previously led the microfabrication process...

June 17, 2020

Tag - NMTC

AGP starts NeuroOne Medical at buy; PT $5.75

NeuroOne developing electrode technology to treat neurological conditions

NeuroOne appoints neural engineering expert, Camilo Andres Diaz-Botia, as director of electrode development

General

More